| NAME |
UMBRALISIB 200MG TAB |
| VA GENERIC NAME |
UMBRALISIB |
| DOSAGE FORM |
TAB |
| FDA MED GUIDE |
Umbralisib_(Ukoniq)_(2021).pdf |
| HAZARDOUS TO DISPOSE |
NO |
| ACTIVE INGREDIENTS |
|
| CS FEDERAL SCHEDULE |
Unscheduled |
| STRENGTH |
200 |
| SINGLE/MULTI SOURCE PRODUCT |
Multisource |
| INACTIVATION DATE |
2022-06-02 00:00:00 |
| UNITS |
MG |
| NATIONAL FORMULARY NAME |
UMBRALISIB TAB |
| CREATE DEFAULT POSSIBLE DOSAGE |
NO |
| POSSIBLE DOSAGES TO CREATE |
No Possible Dosages |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 3
- COPAY EFFECTIVE DATE: 2021-02-22 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
UMBRALISIB 200MG TAB |
| VA PRODUCT IDENTIFIER |
U0095 |
| TRANSMIT TO CMOP |
NO |
| VA DISPENSE UNIT |
TAB |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4040069 |
| EFFECTIVE DATE/TIME |
-
- 2021-02-22 00:00:00
- STATUS: ACTIVE
-
- 2021-02-22 00:00:00
- STATUS: ACTIVE
-
- 2021-02-22 00:00:00
- STATUS: ACTIVE
-
- 2022-06-02 00:00:00
- STATUS: INACTIVE
|
